About Novo Nordisk
At Novo Nordisk, we are driving change to defeat diabetes and other serious chronic conditions.
Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat other serious chronic conditions: haemophilia, growth disorders and obesity.
Headquartered in Denmark, Novo Nordisk employs approximately 41,600 people in 75 countries and markets its products in more than 180 countries.
Novo Nordisk in China
As the leader in the Chinese diabetes market, Novo Nordisk has always been committed to changing diabetes. Since its establishment in 1994, the Novo Nordisk (China) Pharmaceuticals Co., Ltd. has been prominently growing its presence in the country. Headquartered in Beijing, Novo Nordisk China has established a distribution network throughout the country, providing services to patients across mainland China as well as Hong Kong, Macau and Taiwan. As of end-2017, Novo Nordisk had 4,329 employees in China. Novo Nordisk was the first biopharmaceutical company to establish a Research center in China. Located in Beijing, the research center is an integral part of Novo Nordisk’s global R&D system, mandated to develop new products and production technologies in collaboration with the company headquarters. Novo Nordisk Tianjin Plant is a strategic overseas production base of Novo Nordisk. Thanks to massive capital investment and a technological expertise, Novo Nordisk Tianjin Plant is now capable of supplying diabetes treatment products to both the Chinese and the global markets. The unrelenting development of Novo Nordisk in China directly reflects the Company’s long-term commitment to the Chinese market.
Health Care Professionals
Diabetes is a chronic condition caused by the body’s inability to produce or make use of insulin.Read More
Treatment of haemophilia patients, both A and B, and patients with other coagulation factor deficiencies is normally based on replacement therapy,this is substitution of the missing clotting factor.Read More
Growth Hormone Therapy
With over 25 years’ experience, we are committed to the growth hormone category.Read More
Hormone Replacement Therapy
Novo Nordisk is one of the world’s largest manufacturers of HRT products.Read More